Jan‐Erik Berdal
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- Antimicrobial Resistance in Staphylococcus
- Antifungal resistance and susceptibility
Papers in
-
- Infective Endocarditis Diagnosis and Management 2
- Sepsis Diagnosis and Treatment 2
-
- COVID-19 Clinical Research Studies 2
- SARS-CoV-2 and COVID-19 Research 1
- Co-authors
- Jørgen Vildershøj Bjørnholt (5 shared papers)P. Gulbrandsen (1 shared paper)Petter Mowinckel (1 shared paper)Torbjørn Omland (4 shared papers)Christine Monceyron Jonassen (3 shared papers)Trond Egil Ranheim (1 shared paper)Anita Blomfeldt (3 shared papers)Pål Aukrust (2 shared papers)
In The Last Decade
Jan‐Erik Berdal
18 papers receiving 329 citations
Peers
Comparison fields: 5 of 63
- Applied Microbiology and Biotechnology 15
- Infectious Diseases 126
- Critical Care and Intensive Care Medicine 27
- Epidemiology 93
- Clinical Biochemistry 13
Countries citing papers authored by Jan‐Erik Berdal
This map shows the geographic impact of Jan‐Erik Berdal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan‐Erik Berdal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan‐Erik Berdal more than expected).
Fields of papers citing papers by Jan‐Erik Berdal
This network shows the impact of papers produced by Jan‐Erik Berdal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan‐Erik Berdal. The network helps show where Jan‐Erik Berdal may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan‐Erik Berdal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 74 | |
| 2 | 2020 | 54 | |
| 3 | 2011 | 47 | |
| 4 | 2022 | 30 | |
| 5 | 2014 | 27 | |
| 6 | 2007 | 22 | |
| 7 | 2023 | 11 | |
| 8 | 2008 | 11 | |
| 9 | 2020 | 11 | |
| 10 | 2008 | 11 | |
| 11 | 2018 | 8 | |
| 12 | 2023 | 7 | |
| 13 | 2014 | 5 | |
| 14 | 2019 | 5 | |
| 15 | 2013 | 4 | |
| 16 | 2006 | 3 | |
| 17 | 2021 | 2 | |
| 18 | [Long-term antibiotic suppressive therapy for an infected thoracic aorta graft]. | 2003 | 2 |
| 19 | 2025 | 0 |
About Jan‐Erik Berdal
Jan‐Erik Berdal is a scholar working on Epidemiology, Infectious Diseases, Surgery, Neurology and Pulmonary and Respiratory Medicine, having authored 19 papers that have together received 334 indexed citations. Recurring topics across this work include Orthopaedic implants and arthroplasty (3 papers), Orthopedic Infections and Treatments (3 papers), Infective Endocarditis Diagnosis and Management (2 papers), COVID-19 Clinical Research Studies (2 papers), Long-Term Effects of COVID-19 (2 papers), Sepsis Diagnosis and Treatment (2 papers), SARS-CoV-2 and COVID-19 Research (1 paper) and Surgical site infection prevention (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (15 citations), Infectious Diseases (126 citations), Critical Care and Intensive Care Medicine (27 citations), Epidemiology (93 citations) and Clinical Biochemistry (13 citations). Jan‐Erik Berdal has collaborated with scholars based in Norway, Portugal and Uganda. Frequent co-authors include Jørgen Vildershøj Bjørnholt, P. Gulbrandsen, Petter Mowinckel, Torbjørn Omland, Christine Monceyron Jonassen, Trond Egil Ranheim, Anita Blomfeldt, Pål Aukrust, Inge Christoffer Olsen and Olav Dalgård. Their work appears in journals such as Acta Anaesthesiologica Scandinavica, Clinical Microbiology and Infection, Journal of Infection, Journal of Orthopaedic Research® and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.